Morkos, M.B.; Leon, G.; Hong, M.-C.; Garcia, J.A.; Breen, M.J.; Sud, B.; Nguyen, L.
Off-Label Use of Dalbavancin in Enterococcus spp. Abscess and Streptococcus pneumoniae Bacteremia Secondary to Septic Arthritis: A Retrospective Case Report. Pharmacoepidemiology 2024, 3, 307-313.
https://doi.org/10.3390/pharma3040021
AMA Style
Morkos MB, Leon G, Hong M-C, Garcia JA, Breen MJ, Sud B, Nguyen L.
Off-Label Use of Dalbavancin in Enterococcus spp. Abscess and Streptococcus pneumoniae Bacteremia Secondary to Septic Arthritis: A Retrospective Case Report. Pharmacoepidemiology. 2024; 3(4):307-313.
https://doi.org/10.3390/pharma3040021
Chicago/Turabian Style
Morkos, Miriam Banoub, Giovani Leon, Mai-Chi Hong, Joshua Allan Garcia, Martin J. Breen, Bhanu Sud, and Lee Nguyen.
2024. "Off-Label Use of Dalbavancin in Enterococcus spp. Abscess and Streptococcus pneumoniae Bacteremia Secondary to Septic Arthritis: A Retrospective Case Report" Pharmacoepidemiology 3, no. 4: 307-313.
https://doi.org/10.3390/pharma3040021
APA Style
Morkos, M. B., Leon, G., Hong, M.-C., Garcia, J. A., Breen, M. J., Sud, B., & Nguyen, L.
(2024). Off-Label Use of Dalbavancin in Enterococcus spp. Abscess and Streptococcus pneumoniae Bacteremia Secondary to Septic Arthritis: A Retrospective Case Report. Pharmacoepidemiology, 3(4), 307-313.
https://doi.org/10.3390/pharma3040021
